<PAGE> 1
FORM 10-Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
(Mark One)
X Quarterly report pursuant to Section 13 or 15(d) of the Securities
--- Exchange Act of 1934
FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 28, 1996
--- Transition report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
For the transition period from to
--------------- ----------------
Commission file number 0-21074
SUPERCONDUCTOR TECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)
DELAWARE 77-0158076
(State or other jurisdiction of (IRS Employer
incorporation or organization) Identification No.)
460 WARD DRIVE, SUITE F
SANTA BARBARA, CALIFORNIA 93111-2310
(Address of principal executive offices & zip code)
(805) 683-7646
(Registrant's telephone number including area code)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes X No .
--- ---
As of September 28, 1996 there were 6,065,348 shares of the Registrant's Common
Stock outstanding.
<PAGE> 2
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
SUPERCONDUCTOR TECHNOLOGIES INC.
STATEMENT OF OPERATIONS
(UNAUDITED)
<TABLE>
<CAPTION>
THREE MONTHS ENDED NINE MONTHS ENDED
SEPT. 30, 1995 SEPT. 28, 1996 SEPT. 30, 1995 SEPT. 28, 1996
-------------- -------------- -------------- --------------
Net revenues:
<S> <C> <C> <C> <C>
Government contract revenues $ 2,039,000 $ 2,159,000 $ 5,199,000 $ 5,053,000
Commercial product revenues 45,000 40,000 189,000 128,000
----------- ----------- ----------- -----------
Total net revenues 2,084,000 2,199,000 5,388,000 5,181,000
----------- ----------- ----------- -----------
Costs and expenses:
Contract research and
development 1,540,000 1,553,000 3,906,000 4,170,000
Other research and development
and commercial 606,000 562,000 1,904,000 1,982,000
Selling, general and
administrative 670,000 841,000 2,199,000 2,217,000
----------- ----------- ----------- -----------
Total costs and expenses 2,816,000 2,956,000 8,009,000 8,369,000
----------- ----------- ----------- -----------
Loss from operations (732,000) (757,000) (2,621,000) (3,188,000)
Interest income/(expense),Net 68,000 2,000 118,000 59,000
----------- ----------- ----------- -----------
Net loss $ (664,000) $ (755,000) $(2,503,000) $(3,129,000)
=========== =========== =========== ===========
Net loss per share $ (0.11) $ (0.12) $ (0.42) $ (0.51)
Weighted number of shares
outstanding 6,069,160 6,092,226 6,020,405 6,076,770
</TABLE>
(see accompanying notes)
<PAGE> 3
SUPERCONDUCTOR TECHNOLOGIES INC.
BALANCE SHEET
<TABLE>
<CAPTION>
(Unaudited)
ASSETS DECEMBER 31, SEPT. 28,
1995 1996
------------ ------------
Current assets:
<S> <C> <C>
Cash and cash equivalents $ 2,430,000 $ 1,229,000
Short-term investments 2,814,000 653,000
Accounts receivable 1,113,000 1,767,000
Inventory 228,000 397,000
Prepaid expenses and other current assets 248,000 598,000
------------ ------------
Total current assets 6,833,000 4,644,000
Note receivable from related party 150,000 150,000
Property and equipment, net 2,369,000 1,879,000
Patents and licenses, net of accumulated amortization
of $603,000 and $781,000 respectively 2,280,000 2,218,000
Other assets, net of accumulated
amortization of $77,000 and $86,000 respectively 46,000 37,000
------------ ------------
Total assets 11,678,000 8,928,000
============ ============
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses 733,000 1,306,000
Long-term debt --current 405,000 434,000
------------ ------------
Total current liabilities 1,138,000 1,740,000
Long-term debt 453,000 172,000
------------ ------------
Total liabilities 1,591,000 1,912,000
------------ ------------
Stockholders' equity:
Preferred Stock, $.001 par value, 2,000,000 shares authorized,
none issued 0 0
Common Stock, $.001 par value, 15,000,000 shares authorized,
6,026,065 and 6,065,348 shares issued and outstanding 6,000 6,000
Capital in excess of par value 30,122,000 30,180,000
Deficit accumulated during development stage (20,041,000) (23,170,000)
Total stockholders' equity 10,087,000 7,016,000
------------ ------------
Total liabilities and stockholders' equity $ 11,678,000 $ 8,928,000
============ ============
</TABLE>
(see accompanying notes)
<PAGE> 4
SUPERCONDUCTOR TECHNOLOGIES INC.
STATEMENT OF CASH FLOWS
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
(UNAUDITED)
<TABLE>
<CAPTION>
NINE MONTHS ENDED
SEPT. 30, SEPT. 28,
1995 1996
----------- -----------
CASH FLOWS FROM OPERATING ACTIVITIES:
<S> <C> <C>
Net loss $(2,503,000) $(3,129,000)
Adjustments to reconcile net loss to net
cash used for operating activities:
Depreciation, and patent/license amortization 851,000 850,000
Compensation expense associated with stock options granted 52,000 12,000
Changes in assets and liabilities:
Accounts receivable (378,000) (654,000)
Inventory 95,000 (169,000)
Prepaid expenses and other current assets (21,000) (350,000)
Patents and licenses (402,000) (116,000)
Accounts payable and accrued expenses (328,000) 573,000
----------- -----------
Net cash used for operating activities (2,634,000) (2,983,000)
----------- -----------
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of short-term investments 4,575,000 2,161,000
Purchases of property and equipment (377,000) (173,000)
----------- -----------
Net cash provided by investing activities 4,198,000 1,988,000
----------- -----------
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from borrowings 134,000 39,000
Principal payments on long-term obligations (242,000) (291,000)
Proceeds from sale of common stock 93,000 46,000
----------- -----------
Net cash used for financing activities (15,000) (206,000)
----------- -----------
Net increase (decrease) in cash and cash equivalents 1,549,000 (1,201,000)
Cash and cash equivalents at beginning of period 2,452,000 2,430,000
----------- -----------
Cash and cash equivalents at end of period $ 4,001,000 $ 1,229,000
=========== ===========
</TABLE>
(see accompanying notes)
<PAGE> 5
SUPERCONDUCTOR TECHNOLOGIES INC.
NOTES TO FINANCIAL STATEMENTS
A. GENERAL
The unaudited financial information furnished herein reflects all adjustments,
consisting only of normal recurring adjustments, which in the opinion of
management, are necessary to fairly state the Company's financial position, the
results of its operations and its cash flows for the period presented. The
preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the amounts reported in the financial statements and the accompanying
notes. Actual results could differ from those estimates and such differences may
be material to the financial statements. This quarterly report on Form 10-Q
should be read in conjunction with the Company's Form 10-K for the year ended
December 31, 1995. The results of operations for the three months and nine
months ended September 28, 1996 are not necessarily indicative of results for
the entire fiscal year ending December 31, 1996.
In fiscal year 1993, the Company adopted a 13-week quarter reporting period
ending on the Saturday nearest the calendar quarter end. The Company's fiscal
year end is December 31.
B. INVENTORIES
Inventories are stated at the lower of cost (first-in, first out) or market and
consist of the following:
<TABLE>
<CAPTION>
December 31, 1995 September 28, 1996
<S> <C> <C>
Raw Materials $134,000 $191,000
Work-in-Progress 84,000 185,000
Finished Goods 10,000 21,000
-------- --------
Total Inventory $228,000 $397,000
======== ========
</TABLE>
C. PER SHARE INFORMATION
Net loss per common share has been computed using the weighted average number of
common and common equivalent shares (when dilutive) outstanding during each
period. The difference between primary and fully diluted net loss per common
share is not significant.
<PAGE> 6
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
This Quarterly Report on Form 10-Q contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934. These statements are in paragraphs two and
three under "Results of Operations for the periods ended September 28, 1996 and
September 30, 1995" and paragraphs three and four under "Liquidity and Capital
Resources". Actual results could differ materially from those projected in the
forward-looking statements as a result of the risk factors set forth herein.
RESULTS OF OPERATIONS FOR THE THREE-MONTHS AND NINE-MONTHS PERIODS ENDED
SEPTEMBER 28, 1996 AND SEPTEMBER 30, 1995
Total net revenues increased by $115,000, or 6%, from $2,084,000 in the third
quarter of 1995 to $2,199,000 in the third quarter of 1996. This change is due
to the increase in government contract revenue, as well as $40,000 in commercial
revenue generated by cryogenic cooler sales. Government contract revenue
increased by $120,000, or 6%, from $2,039,000 in the third quarter of 1995 to
$2,159,000 in the third quarter of 1996. This increase is attributable to the
receipt of government funding that had been delayed due to government shut downs
during the first half of 1996. Net revenues decreased by $207,000, or 4%, from
$5,388,000 in the first nine months of 1995 to $5,181,000 in the first nine
months of 1996. This revenue change is due to delays in government funding in
the first half of the year.
A significant portion of the Company's revenues have historically consisted of
government research and development contract revenues. In the third quarter of
1996 and for the nine months ended September 28, 1996, three major contracts
accounted for over 60% of the government contract revenues. The Company expects
that government revenue will continue to account for a substantial portion of
total net revenues over the next several quarters. Government contract revenues
have historically fluctuated from period to period. This variability is
attributable to government contract budgeting and funding patterns, as the
government procurement process is lengthy and may involve competing budget
considerations, making the timing of the Company's revenues difficult to
predict. Funds authorized by the government under any development contract may
be reduced or eliminated at any time, and there can be no assurance that the
Company will receive all or any part of the funds under any of the Company's
existing government contracts not yet performed.
As the Company continues to focus on its commercial products, commercial
revenues are expected to increase as a percentage of revenues over the next
several quarters; however, there can be no assurance that such commercial
revenue will increase. Furthermore, as the Company attempts to achieve
commercialization of products, it could encounter seasonality or other currently
unforeseen factors causing additional variability in its results.
Commercial product revenue decreased by $5,000, or 11%, from $45,000 in the
third quarter of 1995 to $40,000 in the third quarter of 1996. Commercial
product revenue decreased by $61,000, or 32%, from $189,000 in the first nine
months of 1995 to $128,000 in the first nine months of 1996. These decreases are
due primarily to the Company's decision to focus less on servicing external
customer needs for films and more on expanding the development efforts of the
Company's products for commercialization.
Contract research and development expenses increased by $13,000 or 1%, from
$1,540,000 in the third quarter of 1995 to $1,553,000 in the third quarter of
1996. This increase is attributable to the increase in contract revenue which is
directly related to contract expenses. Contract research and development
expenses increased by $264,000 or 7%, from $3,906,000 in the first nine months
of 1995 to $4,170,000 in the first nine months of 1996. This increase is due to
an increase in contract overhead expenses as well as expenses incurred from a
contract for which the revenue is not assured.
<PAGE> 7
Other research and development expenses decreased by $44,000 or 7%, from
$606,000 in the third quarter of 1995 to $562,000 in the third quarter of 1996.
This decrease is due to research and development efforts which expenses were
funded under government contracts focused on commercialization of the Company's
product, and therefore, were classified as contract research and development
expenses. Other research and development expenses increased by $78,000 or 4%,
from $1,904,000 in the first nine months of 1995 to $1,982,000 in the first nine
months of 1996. This increase is attributed to the expanded efforts toward
commercialization in the areas of wireless communications, cryocooling and
high-speed computing.
Selling, general and administrative expenses increased by $171,000 or 26%, from
$670,000 in the third quarter of 1995 to $841,000 in the third quarter of 1996.
This increase is primarily attributable to $67,000 of start-up costs for
Cryo-Asia, the joint venture with Alantac (see Part II, Item 5. Other
Information) as well as expenses of $93,000 which were incurred in the secondary
offering and deemed not to have value in any future offering process. However,
the Company stll has a registration statement on file with the SEC and is
proceeding with a public offering. Selling, general and administrative expenses
increased by $18,000 or 1%, from $2,199,000 in the first nine months of 1995 to
$2,217,000 in the first nine months of 1996.
Interest income decreased by $71,000 or 79%, from $90,000 in the third quarter
of 1995 to $19,000 in the third quarter of 1996. Interest income decreased by
$129,000 or 53%, from $245,000 in the first nine months of 1995 to $116,000 in
the first nine months of 1996. The reduction in interest income is primarily due
to a decline in the interest-earning investment balances during these periods as
these funds have been utilized to fund operations.
Interest expense decreased by $5,000 or 23%, from $22,000 in the third quarter
of 1995 to $17,000 in the third quarter of 1996. Interest expense decreased by
$70,000 or 55%, from $127,000 in the first nine months of 1995 to $57,000 in the
first nine months of 1996. These decreases over both periods are due to the
reduction in the Company's long-term portion of note payable and capitalized
lease obligations.
LIQUIDITY AND CAPITAL RESOURCES
Cash and cash equivalents and short-term investments declined by $3,362,000 or
64%, from $5,244,000 on December 31, 1995 to $1,882,000 on September 28, 1996.
The decrease is primarily attributable to funding operating losses of $3.1
million and an increase in inventory of $169,000.
The Company's principal resource commitments at September 28, 1996 consist of
accounts payable and accrued employee compensation of $1,053,000 and $253,000,
respectively, and approximately $606,000 of equipment financing commitments.
The Company believes that its existing cash, cash equivalents and short-term
investments, together with revenue from operations, should provide sufficient
resources to meet its current anticipated liquidity and capital expenditure
requirements for at least the next 12 months.
To date, the Company has been principally involved in research and development
activities, and has recently shifted its focus to commercialization of its HTS
and cold computing products. The Company anticipates that in the next several
quarters it will require significant capital to develop an infrastructure for
the manufacturing of its commercial products. The Company will need to access
either the public or private equity or debt markets or enter into strategic
alliances with its customers to obtain the required capital. There can be no
assurance that capital will be available, if and when required, on acceptable
terms or at all. Any delays in obtaining such capital would have a material
adverse effect on the Company's business, results of operations and financial
condition.
<PAGE> 8
PART II. OTHER INFORMATION
ITEM 5. OTHER INFORMATION
JOINT VENTURE
In May 1996, the Company signed a joint venture agreement with Alantac, a
precision machining house located in Singapore, to establish Cryo-Asia.
Cryo-Asia was established to develop volume manufacturing of STI's proprietary
cooler. The joint venture is sixty percent owned by STI and forty percent owned
by Alantac.
REPRICING
In November 1995, the Board of Directors approved a Stock Option Repricing
Program for all employees. The Repricing Program had been offered on an optional
basis to reprice the outstanding options held by the employees to $4.875, the
closing price of the Company's Common Stock as quoted on the Nasdaq National
Market on November 9, 1995. Fifty-one employees with a total of 135 grants equal
to 797,055 shares were eligible for repricing. No options were repriced as of
December 31, 1995. The employees had until January 15, 1996 to exercise the
repricing option. Forty-two employees chose to reprice 102 of these grants with
a total of 633,268 shares.
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
No reports on Form 8-K were filed during the quarter ended September 28, 1996.
<PAGE> 9
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
SUPERCONDUCTOR TECHNOLOGIES INC.
(Registrant)
Dated: November 7, 1996 /s/ James G. Evans, Jr.
-----------------------
James G. Evans, Jr.
Vice President, Chief Financial Officer
<PAGE> 10
EXHIBIT INDEX
EXHIBIT DESCRIPTION
- ------- -----------
27.1 Financial Data Schedule
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-START> JUL-01-1996
<PERIOD-END> SEP-28-1996
<CASH> 556,000
<SECURITIES> 1,326,000
<RECEIVABLES> 1,767,000
<ALLOWANCES> 0
<INVENTORY> 397,000
<CURRENT-ASSETS> 4,644,000
<PP&E> 7,445,000
<DEPRECIATION> 5,566,000
<TOTAL-ASSETS> 8,928,000
<CURRENT-LIABILITIES> 1,740,000
<BONDS> 0
0
0
<COMMON> 6,000
<OTHER-SE> 30,180
<TOTAL-LIABILITY-AND-EQUITY> 8,928,000
<SALES> 0
<TOTAL-REVENUES> 5,181,000
<CGS> 0
<TOTAL-COSTS> 6,387,000
<OTHER-EXPENSES> 1,982,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 57,000
<INCOME-PRETAX> (3,129,000)
<INCOME-TAX> 0
<INCOME-CONTINUING> (23,170,000)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,129,000)
<EPS-PRIMARY> (.51)
<EPS-DILUTED> (.51)
</TABLE>
